Senior insider sale
Chief Executive Officer at GALECTIN THERAPEUTICS INC — senior position signals high conviction
$1.17M
195.58K shares
What this filing means
SHLEVIN HAROLD H. plans to sell 195.58K shares of GALECTIN THERAPEUTICS INC valued at approximately $1.17M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/12/2025ACC: 0001628280-25-056844
Officer· Chief Executive Officer
Since Jan 2019
195.58K
Shares to sell
$1.17M
Approx. market value
19.79K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
STOCK OPTION
CASH
12/12/2025
19.79KTotal acquired19.79K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/12/2025 | STOCK OPTION CASH | 19.79K | — |
| Total | 19.79K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
175.79K
Market value
$1.05M
12/9/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
19.79K
Market value
$123.0K
12/12/2025
Total
Units
195.58K
Value
$1.17M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/9/2025 | 175.79K | $1.05M | — | Completed |
| Planned — Approximate Date | ||||
12/12/2025 | 19.79K | $123.0K | NASDAQ | Planned |
| Total | 195.58K | $1.17M | ||